Javier Rodríguez

Closest collaborators

The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Fernando Rotellar · 3 shared papers, 2019–2024 · strength 0.47
   • Paper Neoadjuvant therapy versus upfront surgery in resectable pancreatic cancer: reconstructed patient-level meta-analysis o… DOI 10.1093/bjsopen/zrae087↗
   • Paper Delays to surgery following chemoradiotherapy lead to poorer oncologic outcomes in patients with localized pancreatic a… DOI 10.17235/reed.2022.9256/2022↗
   • Paper Use of Machine-Learning Algorithms in Intensified Preoperative Therapy of Pancreatic Cancer to Predict Individual Risk … DOI 10.3390/cancers11050606↗
2. Rubén Hernández-Alcoceba · 1 shared paper, 2026 · strength 0.32
   • Paper Evaluation of methods to increase the expression of cytokine-induced killer cell chemoattractant cytokines in pancreati… DOI 10.1038/s41434-025-00590-1↗
3. María Buñuales · 1 shared paper, 2026 · strength 0.32
   • Paper Evaluation of methods to increase the expression of cytokine-induced killer cell chemoattractant cytokines in pancreati… DOI 10.1038/s41434-025-00590-1↗
4. Mariano Ponz‐Sarvisé · 2 shared papers, 2019–2024 · strength 0.29
   • Paper Neoadjuvant therapy versus upfront surgery in resectable pancreatic cancer: reconstructed patient-level meta-analysis o… DOI 10.1093/bjsopen/zrae087↗
   • Paper Use of Machine-Learning Algorithms in Intensified Preoperative Therapy of Pancreatic Cancer to Predict Individual Risk … DOI 10.3390/cancers11050606↗
5. Daniel Aliseda · 1 shared paper, 2024 · strength 0.21
   • Paper Neoadjuvant therapy versus upfront surgery in resectable pancreatic cancer: reconstructed patient-level meta-analysis o… DOI 10.1093/bjsopen/zrae087↗
6. Javier A. Cienfuegos · 1 shared paper, 2023 · strength 0.18
   • Paper Delays to surgery following chemoradiotherapy lead to poorer oncologic outcomes in patients with localized pancreatic a… DOI 10.17235/reed.2022.9256/2022↗
7. Pablo Sala Elarre · 1 shared paper, 2019 · strength 0.08
   • Paper Use of Machine-Learning Algorithms in Intensified Preoperative Therapy of Pancreatic Cancer to Predict Individual Risk … DOI 10.3390/cancers11050606↗
8. Kenneth H. Yu · 1 shared paper, 2019 · strength 0.08
   • Paper Use of Machine-Learning Algorithms in Intensified Preoperative Therapy of Pancreatic Cancer to Predict Individual Risk … DOI 10.3390/cancers11050606↗
9. Laureano Fernández‐Cruz · 1 shared paper, 2018 · strength 0.06
   • Paper Outcomes after neoadjuvant treatment with gemcitabine and erlotinib followed by gemcitabine-erlotinib and radiotherapy … DOI 10.1007/s00280-018-3682-9↗
10. Santiago Sánchez-Cabús · 1 shared paper, 2018 · strength 0.06
    • Paper Outcomes after neoadjuvant treatment with gemcitabine and erlotinib followed by gemcitabine-erlotinib and radiotherapy … DOI 10.1007/s00280-018-3682-9↗
11. Berta Laquente · 1 shared paper, 2018 · strength 0.06
    • Paper Outcomes after neoadjuvant treatment with gemcitabine and erlotinib followed by gemcitabine-erlotinib and radiotherapy … DOI 10.1007/s00280-018-3682-9↗
12. Àngels Ginés · 1 shared paper, 2018 · strength 0.06
    • Paper Outcomes after neoadjuvant treatment with gemcitabine and erlotinib followed by gemcitabine-erlotinib and radiotherapy … DOI 10.1007/s00280-018-3682-9↗
13. Luis Sabater-Orti · 1 shared paper, 2018 · strength 0.06
    • Paper Outcomes after neoadjuvant treatment with gemcitabine and erlotinib followed by gemcitabine-erlotinib and radiotherapy … DOI 10.1007/s00280-018-3682-9↗
14. Joan Maurel · 1 shared paper, 2018 · strength 0.06
    • Paper Outcomes after neoadjuvant treatment with gemcitabine and erlotinib followed by gemcitabine-erlotinib and radiotherapy … DOI 10.1007/s00280-018-3682-9↗
15. Susana Roselló · 1 shared paper, 2018 · strength 0.06
    • Paper Outcomes after neoadjuvant treatment with gemcitabine and erlotinib followed by gemcitabine-erlotinib and radiotherapy … DOI 10.1007/s00280-018-3682-9↗
16. Marta Martín-Richard · 1 shared paper, 2018 · strength 0.06
    • Paper Outcomes after neoadjuvant treatment with gemcitabine and erlotinib followed by gemcitabine-erlotinib and radiotherapy … DOI 10.1007/s00280-018-3682-9↗
17. Laura Visa · 1 shared paper, 2018 · strength 0.06
    • Paper Outcomes after neoadjuvant treatment with gemcitabine and erlotinib followed by gemcitabine-erlotinib and radiotherapy … DOI 10.1007/s00280-018-3682-9↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.